StageZero Life Sciences to Offer COVID-19 Saliva Test Kits Throughout Canada

Rhea-AI Summary

StageZero Life Sciences has announced the distribution of COVID-19 PCR saliva test kits through Ichor Blood Services in Canadian provinces starting May 5, 2021. This initiative aims to provide accessible and convenient testing for families, companies, and travelers. The saliva-based kits are considered non-invasive and allow for supervised telehealth testing. StageZero is recognized for its multi-cancer detection blood test, Aristotle®, and operates a high-complexity reference lab in Virginia. The company emphasizes that PCR testing is the gold standard for COVID-19 detection.

Positive

• Launch of COVID-19 PCR saliva test kits through retail in multiple provinces.
• Non-invasive testing method enhances accessibility for Canadians.
• StageZero's existing reputation in disease detection strengthens market position.

Negative

• None.

TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, today announced it will distribute via its partner Ichor Blood Services through a Canadian retail outlet, COVID-19 PCR saliva test kits in British Columbia, Alberta, Saskatchewan, Manitoba and Ontario beginning May 5.

"StageZero is proud to make these kits available to Canadians to enable immediate and convenient PCR testing, at home, via supervised telehealth, for families, companies and travelers," said James Howard-Tripp, Chairman and CEO of StageZero Life Sciences. "COVID-19 PCR testing is considered the gold standard for helping to determine if someone is infected with SARS-CoV-2, the virus that causes COVID-19, and saliva-based PCR testing is an easy, non-invasive way to collect a sample".

About StageZero Life Sciences, Ltd.

StageZero Life Sciences is dedicated to the early detection of multiple diseases through whole blood tests. The Company's next-generation test, Aristotle®, is the first-ever multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. StageZero's full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups, and the Company operates a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia. In addition, leveraging its specialty in polymerase chain reaction (PCR) testing for the early identification of cancer through blood, StageZero also provides both COVID PCR testing (swab and saliva) and blood test analysis (Antibody testing). For more information, please visit www.stagezerolifesciences.com.

About Ichor Blood Services

Ichor is a Calgary based medical services company that performs lab specimen collection and facilitates a number of private and public tests including COVID-19 testing and video witnessing services.

Forward-Looking Statements

This press release contains forward-looking statements identified by words such as "expects", "will" and similar expressions, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Company's actual events to differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.

STAGEZERO LIFE SCIENCES LTD.
James Howard-Tripp
Chairman & CEO

For further information please contact:
Rebecca Greco
Investor Relations
Tel: 1-855-420-7140 ext. 1838
rgreco@stagezerols.com

SOURCE: StageZero Life Sciences Ltd.

View source version on accesswire.com:
https://www.accesswire.com/644695/StageZero-Life-Sciences-to-Offer-COVID-19-Saliva-Test-Kits-Throughout-Canada

FAQ

What is the significance of StageZero Life Sciences distributing COVID-19 PCR saliva test kits?

This distribution allows for convenient, accessible, and non-invasive COVID-19 testing for individuals and organizations across Canada.

When did StageZero Life Sciences start distributing saliva test kits for COVID-19?

The distribution of the COVID-19 PCR saliva test kits began on May 5, 2021.

Which provinces in Canada are receiving the COVID-19 test kits from StageZero Life Sciences?

The test kits are being distributed in British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario.

How does the COVID-19 saliva test provided by StageZero compare to traditional testing?

The saliva test is considered non-invasive and allows for supervised testing via telehealth, making it more convenient than traditional swab tests.

What is the role of Ichor Blood Services in StageZero's COVID-19 testing initiative?

Ichor Blood Services is partnering with StageZero to facilitate the distribution of the COVID-19 PCR saliva test kits at retail outlets.